Advancing Clinical Therapeutics Globally For Hiv/aids And Other Infections
Clinical trials sponsored by Advancing Clinical Therapeutics Globally For Hiv/aids And Other Infections, explained in plain language.
-
Can antibodies keep HIV in check without daily pills?
Disease control OngoingThis study tests whether two lab-made antibodies can safely control HIV in people who stop their regular antiretroviral therapy for a short time. Thirty-two adults in Sub-Saharan Africa who are currently on HIV treatment will receive either the antibodies or a placebo. The goal i…
Phase: PHASE1 • Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
HIV study seeks blanket consent for future genetic tests on stored samples
Knowledge-focused OngoingThis study asks people who have taken part in HIV clinical trials to give permission for their stored blood and tissue samples to be used in future research, including genetic testing. The goal is to have a large collection of samples ready for studies that haven't been planned y…
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC